Evidence map›Paper›PMID 41060150›Full record

ArticleInvestigative ophthalmology & visual science2025

Hidden Splicing Variants in Inherited Retinal Degeneration: Discovery and Functional Insight.

Yu-Shu Huang, Wen-Ting Lu, I-Hsuan Chiu, Pei-Miao Chien, Yu-An Chen, Chien-Yu Lin, Chang-Hao Yang, Chung-May Yang, Chao-Wen Lin, Jacob Shujui Hsu and 2 more

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. The mutational and clinical spectrum ofFrontiers in genetics · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yu-Shu HuangGraduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Wen-Ting LuDepartment of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan.
I-Hsuan ChiuDepartment of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan.
Pei-Miao ChienGraduate Institute of Medical Genomics and Proteomics, College of Medicine, National Taiwan University, Taipei, Taiwan.
Yu-An ChenGraduate Institute of Medical Genomics and Proteomics, College of Medicine, National Taiwan University, Taipei, Taiwan.
Chien-Yu LinDepartment of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
Chang-Hao YangDepartment of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
Chung-May YangDepartment of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
Chao-Wen LinDepartment of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
Jacob Shujui HsuGraduate Institute of Medical Genomics and Proteomics, College of Medicine, National Taiwan University, Taipei, Taiwan.
Pei-Lung ChenGraduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Ta-Ching ChenDepartment of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To enhance the molecular diagnosis of inherited retinal degeneration (IRD) by systematically identifying pathogenic splicing variants and characterizing their transcript-level consequences. Methods: We analyzed 738 IRD families who underwent targeted gene panel sequencing. A splicing variant detection pipeline, integrating two computational algorithms (SpliceAI and dbscSNV_ADA) with functional validation via minigene assays, was implemented to detect splice-disrupting variants beyond canonical sites. Results: Splicing variants accounted for 14% of genetically diagnosed families. Of these, 4% were newly identified through our combined computational and experimental platform. Notably, 28% of all splice-disrupting variants, located in noncanonical, exonic, or deep-intronic regions, would likely have been missed by conventional analysis pipelines, which typically prioritize protein-coding changes and canonical splice sites, and often lack systematic evaluation of splicing effects beyond these regions. Five recurrent splice-disrupting variants were observed across multiple families, including EYS:c.5644+5G>A, which caused exon truncation and was found in 11 unrelated families. Functional assays confirmed aberrant splicing, and the associated phenotypes were consistent with known disease presentations. Conclusions: This study demonstrates the utility of a combined splicing variant detection platform in uncovering hidden pathogenic variants and improving IRD diagnostic yield. These findings have implications for refining genetic testing and guiding the development of splicing-targeted therapies.

Indexed as

Eye ProteinsMutationRetinal DegenerationRNA SplicingAdultExonsFemaleHumansMaleMiddle AgedPedigreeEye Proteins

Identifiers

PMID41060150
PMCPMC12517372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.